Increased Myeloid-Derived Suppressor Cells in Newly Diagnosed Multiple Sclerosis: Immunophenotyping and Functional Validation
Archives of Neuropsychiatry · 2026
DOI: 10.29399/npa.29385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Neuropsychiatry, 2026. Verfasst von Nazire Pınar Acar Özen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Türkiye. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
- Hacettepe University Multiple Sclerosis Research and Application Center, Ankara, Türkiye.
- Hacettepe University Cancer Institute, Department of Basic Oncology, Ankara, Türkiye.
- University of Health Sciences, Gülhane Faculty of Medicine, Department of Medical Biology, Ankara, Türkiye.
Zitieren
APA
Özen, N. P. A., Yanık, H., & Tuncer, A. (2026). Increased Myeloid-Derived Suppressor Cells in Newly Diagnosed Multiple Sclerosis: Immunophenotyping and Functional Validation. Archives of Neuropsychiatry. https://doi.org/10.29399/npa.29385
Vancouver
Özen NPA, Yanık H, Tuncer A. Increased Myeloid-Derived Suppressor Cells in Newly Diagnosed Multiple Sclerosis: Immunophenotyping and Functional Validation. Archives of Neuropsychiatry. 2026. doi:10.29399/npa.29385
BibTeX
@article{zen2026,
author = {Özen, Nazire Pınar Acar and Yanık, Hamdullah and Tuncer, Aslı},
title = {Increased Myeloid-Derived Suppressor Cells in Newly Diagnosed Multiple Sclerosis: Immunophenotyping and Functional Validation},
journal = {Archives of Neuropsychiatry},
year = {2026},
doi = {10.29399/npa.29385}
}
EUVIMED